Table 2 Basic patient characteristics and results of hormonal testing in FHA women with and without PCOM

Age (years)

26 (21;30)

26 (21;28)

26 (23;28)

0.731

BMI (kg/m²)

20.0 (18.5;21.6)

20.4 (18.6;23.2)

21.5 (19.6;23.6)

0.131

TSH (IU/mL)

1.78 (1.17;2.04)

1.49 (1.08;2.36)

1.41 (1.05;1.93)

0.400

FSH (mIU/mL)

4.0 (2.6;6.1)

4.6 (3.5;6.5)

5.7 (4.4;7.6)

0.034

LH (mIU/mL)

2.6 (1.2;4.9)^b

2.6 (1.3;6.3)^c

4.7 (3.4;7.0)^{b c}

0.001

Prolactin (ng/mL)

7.9 (6.5;12.2)^b

9.3 (6.6;13.1)

11.8 (9.0;15.4)^b

0.013

Estradiol (pg/mL)

23 (16;35)^b

30 (11;45)^c

71 (50;97)^{b c}

 < 0.001

Testosterone (pg/mL)

0.22 (0.13;0.30)

0.22 (0.15;0.30)

0.25 (0.17;0.31)

0.695

Androstenedione (ng/mL)

1.29 (0.93;2.10)

1.65 (1.09;2.62)

1.54 (1.18;2.04)

0.269

DHEAS (µg/mL)

2.01 (1.47;3.25

2.33 (1.56;2.84)

2.18 (1.76;2.74)

0.926

SHBG (nmol/L)

79.4 (60.3;120.9)

68.3 (37.7;99.8)

81.2 (61.;104.5)

0.144

AMH (ng/mL)

2.03 (1.40;2.50)^{a b}

6.38 (4.34;10.10)^{a c}

3.08 (2.24;4.10)^{b c}

 < 0.001